Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(03): 322-333
DOI: 10.1055/s-0042-1760312
Review Article

Imaging Recommendations for Diagnosis, Staging and Management of Treatment-Related Complications in Cancer

Sumit Mukhopadhyay
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Saugata Sen 
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Priya Ghosh 
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Anisha Gehani 
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Anurima Patra
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Aditi Chandra
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Argha Chatterjee 
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Dayananda Lingegowda
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Bharat Gupta
1   Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, West Bengal, India
,
Meenu Gupta
2   Department of Radiology & Imaging, Medanta Hospital, Lucknow, Uttar Pradesh, India
,
Prakash Venugopal
3   Department of Radiology and Imaging, Sri Ramakrishna Hospital, Coimbatore, Tamil Nadu, India
,
Amrita Chakraborty
4   Department of Radiology and Imaging, HCG EKO Cancer Center, Kolkata, West Bengal, India
,
Ketul K. Pathak
5   Department of Radiology, Institute of Kidney Diseases and Research Center - Institute of Transplant Sciences, Ahmedabad, Gujarat, India
,
Pradipta Kumar Mishra
6   Department of Radiodiagnosis, Acharya Harihar Regional Cancer Center, Cuttack, Odisha, India
,
Jeevitesh Khoda 
7   Department of Radiology and Interventional Oncology Services, Rajiv Gandhi Cancer Institute and Research Center, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Precision medicine is becoming increasingly common in oncology, with treatments tailored to individual patients and cancer. By integrating these underlying concepts of health care, chemotherapy and radiotherapy can be tailored to improve safety and efficacy. On the other hand, oncology treatment regimens may result in local and systemic changes and complications depending on the type of treatment. For the proper and prompt management of cancer patients, it is essential to interpret this posttreatment imaging correctly. This article aims at guiding treating physicians to be able to distinguish complications from expected posttreatment changes.

Keywords

complications - oncology - radiology - review


Publication History

Article published online:
01 March 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Badalamenti G, Messina C, De Luca I, Musso E, Casarin A, Incorvaia L. Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives. Radiol Med (Torino) 2019; 124 (04) 259-265
    CrossrefPubMedGoogle Scholar
  • 2 Kucha N, Soni TP, Jakhotia N. et al. A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients. Cancer Treat Res Commun 2020; 25: 100223
    CrossrefPubMedGoogle Scholar
  • 3 Ngo D, Jia JB, Green CS, Gulati AT, Lall C. Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights Imaging 2015; 6 (06) 665-677
    CrossrefPubMedGoogle Scholar
  • 4 Stone JB, DeAngelis LM. Cancer-treatment-induced neurotoxicity–focus on newer treatments. Nat Rev Clin Oncol 2016; 13 (02) 92-105
    CrossrefPubMedGoogle Scholar
  • 5 Jairam V, Lee V, Park HS. et al. Treatment-related complications of systemic therapy and radiotherapy. JAMA Oncol 2019; 5 (07) 1028-1035
    CrossrefPubMedGoogle Scholar
  • 6 Thompson JA, Schneider BJ, Brahmer J. et al. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022; 20 (04) 387-405 DOI: 10.6004/jnccn.2022.0020.
    CrossrefPubMedGoogle Scholar
  • 7 Baden LR, Swaminathan S, Angarone M. et al. Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14 (07) 882-913 DOI: 10.6004/jnccn.2016.0093.
    CrossrefPubMedGoogle Scholar
  • 8 NCG palliative care guidelines 2021 [Internet]. NCG; 2021. . Accessed April 1, 2022, at: https://tmc.gov.in/ncg/index.php/guidelines/palliative-care-guidelines
    Google Scholar
  • 9 NCG. Approach to managing malignant bowel obstruction [Internet]. NCG Guidelines for palliative care. 2021 . Accessed April 1, 2022, at: https://tmc.gov.in/ncg/images/Approach%20to%20managing%20Malignant%20Bowel%20Obstruction.pdf
    PubMedGoogle Scholar
  • 10 Kanda T, Wakabayashi Y, Zeng F. et al. Imaging findings in radiation therapy complications of the central nervous system. Jpn J Radiol 2018; 36 (09) 519-527
    CrossrefPubMedGoogle Scholar
  • 11 Albano D, Benenati M, Bruno A. et al; Young SIRM Working Group. Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe. Insights Imaging 2021; 12 (01) 76
    CrossrefPubMedGoogle Scholar
  • 12 Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging 2018; 9 (06) 1057-1075
    CrossrefPubMedGoogle Scholar
  • 13 Shah R, Vattoth S, Jacob R. et al. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics 2012; 32 (05) 1343-1359
    CrossrefPubMedGoogle Scholar
  • 14 Leao DJ, Craig PG, Godoy LF, Leite CC, Policeni B. Response assessment in neuro-oncology criteria for gliomas: practical approach using conventional and advanced techniques. AJNR Am J Neuroradiol 2020; 41 (01) 10-20
    CrossrefPubMedGoogle Scholar
  • 15 Chukwueke UN, Wen PY. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice. CNS Oncol 2019; 8 (01) CNS28
    CrossrefPubMedGoogle Scholar
  • 16 Linhares P, Carvalho B, Figueiredo R, Reis RM, Vaz R. Early pseudoprogression following chemoradiotherapy in glioblastoma patients: the value of RANO evaluation. J Oncol 2013; 2013: 690585
    CrossrefPubMedGoogle Scholar
  • 17 Dietrich J, Klein JP. Imaging of cancer therapy–induced central nervous system toxicity. Neurol Clin [Internet]. 2014. Accessed December 13, 2022, at: https://www.neurologic.theclinics.com/article/S0733-8619(13)00087-X/abstract
    Google Scholar
  • 18 Sindhwani G, Arora M, Thakker VD, Jain A. MRI in chemotherapy induced leukoencephalopathy: report of two cases and radiologist's perspective. J Clin Diagn Res 2017; 11 (07) TD08-TD09
    PubMedGoogle Scholar
  • 19 Glastonbury CM, Parker EE, Hoang JK. The postradiation neck: evaluating response to treatment and recognizing complications. AJR Am J Roentgenol 2010; 195 (02) W164-71
    CrossrefPubMedGoogle Scholar
  • 20 Gehani A, Sen S, Chatterjee S, Mukhopadhyay S. Imaging features of postradiotherapy changes in head and neck cancers. Indian J Radiol Imaging 2021; 31 (03) 661-669
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Nishino M, Ramaiya NH, Awad MM. et al. PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course. Clin Cancer Res 2016; 22 (24) 6051-6060
    CrossrefPubMedGoogle Scholar
  • 22 Terbuch A, Tiu C, Candilejo IM. et al. Radiological patterns of drug-induced interstitial lung disease (DILD) in early-phase oncology clinical trials. Clin Cancer Res 2020; 26 (18) 4805-4813
    CrossrefPubMedGoogle Scholar
  • 23 Weber JS, Kähler KC, Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012; 30 (21) 2691-2697
    CrossrefPubMedGoogle Scholar
  • 24 Lee H, Lee HY, Sun J-M. et al. Transient asymptomatic pulmonary opacities during osimertinib treatment and its clinical implication. J Thorac Oncol 2018; 13 (08) 1106-1112
    CrossrefPubMedGoogle Scholar
  • 25 Benveniste MF, Gomez D, Carter BW. et al. Recognizing radiation therapy-related complications in the chest. Radiographics 2019; 39 (02) 344-366
    CrossrefPubMedGoogle Scholar
  • 26 Yeh ETH, Tong AT, Lenihan DJ. et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 2004; 109 (25) 3122-3131
    CrossrefPubMedGoogle Scholar
  • 27 Čelutkienė J, Pudil R, López-Fernández T. et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail 2020; 22 (09) 1504-1524
    CrossrefPubMedGoogle Scholar
  • 28 Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG. Cancer and its association with the development of coronary artery calcification: an assessment from the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2015; 4 (11) e002533
    CrossrefPubMedGoogle Scholar
  • 29 Wang DY, Salem J-E, Cohen JV. et al. Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol 2018; 4 (12) 1721-1728
    CrossrefPubMedGoogle Scholar
  • 30 Gatti M, Calandri M, Bergamasco L. et al. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Radiol Med (Torino) 2020; 125 (04) 348-355
    CrossrefPubMedGoogle Scholar
  • 31 Vernuccio F, Godfrey D, Meyer M. et al. Local tumor control and patient outcome using stereotactic body radiation therapy for hepatocellular carcinoma: iRECIST as a potential substitute for traditional criteria. AJR Am J Roentgenol 2019; 213 (06) 1232-1239
    CrossrefPubMedGoogle Scholar
  • 32 Hennedige TP, Hallinan JTPD, Leung FP. et al. Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions. Eur Radiol 2016; 26 (02) 398-406
    CrossrefPubMedGoogle Scholar
  • 33 UpToDate [Internet]. Accessed April 1, 2022, at: https://www.uptodate.com/contents/chemotherapy-and-radiation-related-hemorrhagic-cystitis-in-cancer-patients
    Google Scholar
  • 34 Hutchins TA, Peckham M, Shah LM. et al; Expert Panel on Neurological Imaging. ACR Appropriateness Criteria® low back pain: 2021 update. J Am Coll Radiol 2021; 18 (11S, Supplement): S361-S379
    CrossrefPubMedGoogle Scholar
  • 35 Kransdorf MJ, Murphey MD, Wessell DE. et al; Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® soft-tissue masses. J Am Coll Radiol 2018; 15 (5S): S189-S197
    CrossrefPubMedGoogle Scholar
  • 36 Shah LM, Jennings JW, Kirsch CFE. et al; Expert Panels on Neurological Imaging, Interventional Radiology, and Musculoskeletal Imaging. ACR Appropriateness Criteria® management of vertebral compression fractures. J Am Coll Radiol 2018; 15 (11S): S347-S364
    CrossrefPubMedGoogle Scholar
  • 37 Lee CH, Dershaw DD, Kopans D. et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol 2010; 7 (01) 18-27
    CrossrefPubMedGoogle Scholar
  • 38 Bevers TB, Anderson BO, Bonaccio E. et al; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009; 7 (10) 1060-1096
    CrossrefPubMedGoogle Scholar
  • 39 Johnson CB, Sulpher J, Stadnick E. Evaluation, prevention and management of cancer therapy-induced cardiotoxicity: a contemporary approach for clinicians. Curr Opin Cardiol 2015; 30 (02) 197-204
    CrossrefPubMedGoogle Scholar
  • 40 Huang H, Nijjar PS, Misialek JR. et al. Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2017; 19 (01) 34
    CrossrefPubMedGoogle Scholar